| |
|
EVENT DETAILS |
Early-stage companies will have to obtain funding or go through an exit process at some point in time. Since intellectual property (IP) often represents the bulk of an early stage company's assets, investors will typically conduct due diligence on the IP during their evaluation process. Key areas that are evaluated include ownership of the IP, strength of the company's IP, & freedom-to-operate. Join us May 30 to get a primer on how to prepare for IP due diligence from Douglas Portnow & Piers Blewett from the IP law firm Schwegman Lundberg & Woessner.
About the Speakers
Piers Blewett is a patent attorney & principal at Schwegman Lundberg & Woessner. He is a former Chief Patent Counsel (International), Vice President & associate General Counsel at Kimberly Clark Corporation. His practice includes strategic IP counseling, patent prosecution (US & foreign), patent validity, infringement & clearance analysis & opinions, global patent litigation, & IP due diligence work.
Doug Portnow is a registered patent attorney & a Principal of Schwegman Lundberg & Woessner. His practice focuses on patent preparation & prosecution, IP due diligence & strategic counseling in the medical device & mechanical technologies. Prior to joining Schwegman, Doug was a Member at Wilson Sonsini Goodrich & Rosati & an associate at Townsend & Townsend & Crew LLP (now Kilpatrick Townsend & Stockton). Before entering the legal profession, Doug worked for over a decade in the medical device industry holding engineering & management positions at start-ups & publicly traded companies commercializing critical care products, vascular grafts, surgical instruments, stents, stent delivery systems, RF ablation catheters, embolic protection devices, & heart failure implants. Doug has been recognized as a Rising Star by Northern California Super Lawyers.
|
|
|
|
|
|
